Emerald Therapeutics
Latest round
- Series B
Last raised
- Jul 2014
Total raised
- $1.9M
Investors
- 2
About Emerald Therapeutics
Founded in 2010, Emerald Therapeutics is based in Menlo Park, US, and specializes in providing innovative laboratory solutions. The company was co-founded by Brian Frezza and Dj Kleinbaum.Emerald Cloud Lab specializes in providing a remote-controlled life sciences laboratory platform that empowers researchers and organizations to conduct experiments and analyses without the constraints of a physical lab. The company’s primary offering allows users to design, execute, and analyze experiments through a sophisticated web interface that connects them to automated laboratory equipment in a centralized facility. This product is aimed at addressing challenges faced by researchers in various sectors, including pharmaceuticals, biotechnology, and academic institutions, who require high throughput and precision while minimizing operational costs and logistical complexities. Emerald Cloud Lab serves a diverse client base, which includes research institutions, biotech companies, and academic laboratories across North America and Europe, enabling them to accelerate their research and development timelines.Emerald Cloud Lab generates revenue primarily through a subscription-based model, allowing clients to access its laboratory services and platform features on a recurring basis. This transactional structure includes tiered pricing plans based on the volume of experiments conducted, level of service, or additional features utilized by the clients. Clients typically engage with the company on a B2B basis, establishing partnerships that provide them with the tools necessary for extensive research projects. Additionally, the company offers specific flagship services that may cater to specialized needs within the life sciences sector, enhancing the value provided to its clients. The company is focused on launching new products designed to improve user experience and broaden its market reach. Additionally, Emerald Therapeutics plans to expand into new geographic markets, specifically targeting regions in Europe and Asia by 2025, to cater to a growing global demand for remote laboratory services.
Who invested in Emerald Therapeutics
2 investors across 1 round
See all investors in Emerald Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 1, 2014
Amount
$1.9M
Investors
Questions about Emerald Therapeutics
Who invested in Emerald Therapeutics?
Emerald Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Emerald Therapeutics raised?
Emerald Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Emerald Therapeutics last raise money?
Emerald Therapeutics's most recent round on record is a Series B, in Jul 2014.
What does Emerald Therapeutics do?
Founded in 2010, Emerald Therapeutics is based in Menlo Park, US, and specializes in providing innovative laboratory solutions.
Where is Emerald Therapeutics headquartered?
Emerald Therapeutics is headquartered in Menlo Park, US.
Which VCs invest in companies like Emerald Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Emerald Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Emerald Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.